TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Blair Leavitt, MD
Huntington Study Group/University of British Columbia
Principal Investigator - Christopher Ross, MD, PhD
Huntington Study Group/Johns Hopkins University School of Medicine
Principal Investigator - Ira Shoulson, MD
Huntington Study Group/University of Rochester
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary
Calgary, Alberta, Canada
- University of Alberta Glenrose Rehab Hospital
Edmonton, Alberta, Canada
- University of British Columbia
Vancouver, British Columbia, Canada
- University of British Columbia
London, Ontario, Canada
- the Centre for Addiction and Mental Health
Markham, Ontario, Canada
- Hotel-Dieu Hospital-Chum
Montreal, Quebec, Canada
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Mayo Clinic Arizona
Scottsdale, Arizona, United States
- University of California San Diego
La Jolla, California, United States
- Ucla Medical Center
Los Angeles, California, United States
- University of California Davis
Sacramento, California, United States
- University of California San Francisco
San Francisco, California, United States
- Colorado Neurological Institute
Englewood, Colorado, United States
- Institute of Neurodegenerative Disorders
New Haven, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- University of Miami
Miami, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Medical College of Georgia
Augusta, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Iowa
Iowa City, Iowa, United States
- University of Kansas
Kansas City, Kansas, United States
- Hereditary Neurological Disease Centre
Wichita, Kansas, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Boston University
Boston, Massachusetts, United States
- Massachusetts General Hospital
Charlestown, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Albany Medical College
Albany, New York, United States
- North Shore-Lij Health System
Manhasset, New York, United States
- Columbia University Medical Center
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- Ohio State University Parkinson'S Center
Columbus, Ohio, United States
- Penn State Milton & Hershey Medical College
Hershey, Pennsylvania, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- University of Tennessee-Memphis
Memphis, Tennessee, United States
- Baylor College of Medicine
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2005
- Primary completion
- 31 Aug 2007
- Completion
- 31 Jul 2007
- Last update posted
- 27 Dec 2007
- Registered enrollment
- 300
- Registry id
- NCT00146211
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.